Bookmark and Share
Creatine (CID 586) - Compound BioActivity Data
.
BioActivity Outcomes:
Inactive(11)
 
 
Inconclusive(1)
 
 
Unspecified(9)
 
 
Top Targets:
MFS(1)
 
 
SLC5-6-like s..(1)
 
 
BioAssay Types:
Literature(9)
 
 
BioActivity Types:
Ki(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 21    Data Row: 21   Total Pages: 2   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103187076]
Ki 3200Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting [AID630741, Type: Literature]Proton-coupled amino acid transporter 1 [gi:51316800]
View
2
[SID103187076]
Reaction rate of creatine kinase activity is determined at 1 mM concentration [AID54681, Type: Literature]
View
3
[SID103187076]
In vitro [14C]- creatine uptake (1 mM) was determined in rat A10 smooth muscle cells at a concentration of (1 mM) [AID94676, Type: Literature]
View
4
[SID103187076]
In vitro kinase activity (phosphorylation) of creatine kinase was determined [AID220042, Type: Literature]
View
5
[SID103187076]
Inhibition of creatine transport was assessed from Percent inhibition of [C14] creatine uptake [AID227430, Type: Literature]
View
6
[SID103187076]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature]
View
7
[SID103187076]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature]
View
8
[SID103187076]
Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature]
View
9
[SID103187076]
TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.010? uM, Creatine: 500 uM) in OCTN2-expressing HEK293 cells [AID682314, Type: Literature]Solute carrier family 22 member 5 [gi:8928257]
View
10
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other]
View
11
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other]
View
12
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other]
View
13
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other]
View
14
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other]
View
15
[SID74369]
NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other]
View
16
[SID74369]
NCI In Vivo Anticancer Drug Screen. Data for tumor model Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice [AID180, Type: other]
View
17
[SID74369]
NCI In Vivo Anticancer Drug Screen. Data for tumor model Adenocarcinoma 755 (subcutaneous) in C57BL/6 mice [AID218, Type: other]
View
18
[SID74369]
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other]
View
19
[SID74369]
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other]
View
20
[SID74369]
NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice [AID270, Type: other]
View